CenterVue a Revenio Group company Giuliano Barbaro R&D Director - - PowerPoint PPT Presentation

centervue
SMART_READER_LITE
LIVE PREVIEW

CenterVue a Revenio Group company Giuliano Barbaro R&D Director - - PowerPoint PPT Presentation

CenterVue a Revenio Group company Giuliano Barbaro R&D Director 7^ International Congress on OCT Angiography and advances in OCT Rome, 14 th December 2019 Fundus Automated Perimetry COMPASS Microperimetry MAIA Fundus Automated Perimetry is


slide-1
SLIDE 1

CenterVue

a Revenio Group company

Giuliano Barbaro R&D Director

7^ International Congress on OCT Angiography and advances in OCT Rome, 14th December 2019

slide-2
SLIDE 2

Fundus Automated Perimetry COMPASS

Fundus Automated Perimetry is a technique that images the retina during visual field testing, enabling a correlation to be made between visual function and retinal structure. Retinal tracking improves the quality of the perimetric exam.

Wide-field imaging with EIDON

EIDON is a Wide-Field confocal fundus imaging system with white LED illumination able to capture TrueColor images.

Retinal imaging and Alzheimer Disease

Fundus imaging with DRSplus

DRSplus confocal fundus imaging system by uses white LED illumination to produce TrueColor and detail-rich images.

Microperimetry MAIA

MAIA represents the latest advance in confocal microperimetry.

Spectrally resolved auto- fluorescence

CONFOCAL IMAGING WITH WHITE LED ILLUMINATION COMPUTER-ASSISTED ACQUISITION

Fundus Imaging

Retinal imaging and AI

slide-3
SLIDE 3

Why and how is this image better?

slide-4
SLIDE 4

Chromaticity graph: distribution of all pixels in

  • ne image in color space
slide-5
SLIDE 5

EIDON Number of unique colors in image: 300.000 FUNDUS CAMERA Number of unique colors in image: 90.000

slide-6
SLIDE 6

Screening performance of an automated image analysis software for the detection of diabetic retinopathy using conventional fundus photography or a confocal white LED device. V. Sarao, D. Veritti, P. Lanzetta

N = 144 SENSITIVITY* SPECIFICITY* EIDON 94.7% 90.3% FUNDUS CAMERA 90.7% 76.2%

(*) for referable retinopathy

ENHANCED COLOR CONTENT + HIGH RESOLUTION = IMPROVED DIAGNOSTIC ACCURACY